MedTrace Logo

Gene Expression in Cumulus Cells to Predict Pregnancy

NCT01732900 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 133

Last updated 2014-07-14

No results posted yet for this study

Summary

The purpose of this study is to determine the performance of a genetic assay, GemART, in cumulus cells predictive of embryo viability, and pregnancy success in women undergoing in vitro fertilization (IVF). Performance is defined as success rate per embryo transferred, as measured by the implantation rate of embryos transferred.

Conditions

Interventions

OTHER

Morphology

Embryos selected for transfer will be based upon morphology alone.

OTHER

GemART assay

Embryos selected for transfer will be based upon morphology and GemART assay.

Sponsors & Collaborators

  • Gema Diagnostics

    lead INDUSTRY

Principal Investigators

  • John Jarrett, MD · IVF Indiana

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01732900 on ClinicalTrials.gov